WA
HZNP

WP Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

WP Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,400
Closed -$278K – 109
2023
Q3 		$278K Sell
2,400
-200
-8% -$21.5K 0.11% 86
2023
Q2 		$267K Sell
2,600
-50
-2% -$5.28K 0.11% 88
2023
Q1 		$289K Sell
2,650
-150
-5% -$16.6K 0.12% 85
2022
Q4 		$319K Buy
+2,800
New +$233K 0.14% 83
2022
Q3 		– Sell
-3,000
Closed -$239K – 109
2022
Q2 		$239K Buy
3,000
+100
+3% +$9.47K 0.1% 100
2022
Q1 		$305K Buy
2,900
+400
+16% +$39K 0.13% 92
2021
Q4 		$269K Buy
+2,500
New +$273K 0.11% 92

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

WP Advisors's HZNP Position: Q4 2023 in Review

WP Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,400 shares — an estimated $278K sold.

WP Advisors first reported a position in HZNP in Q4 2021 and held it in 7 quarters. The position peaked at $319K in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • WP Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • WP Advisors sold 2,400 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $278K.
  • WP Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 7 quarters.
  • WP Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $319K in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on WP Advisors's 13F filing for Q4 2023, filed 31 Jan 2024.